FDA Grants Priority Review to Pemigatinib for Cholangiocarcinoma Treatment
- This topic has 0 replies, 1 voice, and was last updated 4 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
FDA Grants Priority Review to Pemigatinib for Cholangiocarcinoma Treatment
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.